Two proteins, barnase, the extracellular ribonuclease of Bacillus amyloliquefaciens, and barstar, its intracellular inhibitor, are used as a model system for the study of protein folding and protein-protein interactions. Barnase is one of an homologous group of ribonucleases occurring in both prokaryotes and eukaryotes. Recombinant DNA techniques are being applied with three major aims: (1) to facilitate production of wild type and mutant proteins; (2) to examine the structural and control sequences of the genes; and (3) to make specific changes in the sequences to test theories of folding and to probe the barnase-barstar interaction. Both proteins can now be obtained from recombinant genes in E. coli where expression of barstar counters the lethal effect of barnase expression. The structures of both proteins and their complex are known, barnase at 1.5 angstrom resolution. Crystal structures of several barnase-barstar pairs having complementary mutations in the interface, obtained by an in vivo selective technique, have been solved, providing insight into the mechanisms that determine the strength of the bond. Barstar also inhibits a group of RNases from Streptomyces strains. These enzymes are distantly related to barnase with a sequence identity of only 25%. Among the four such enzymes in hand, identities ranges from 40% to 70%. The structures of two, RNases Sa and St, are known from work on nonrecombinant material and a third, RNase Sa2, from our recombinant material. The structure of recombinant RNase Sa in complex with barstar has also been solved.A phage display system has been developed for selection of varieties or homologs of barstar that bind tightly to barnase or its mutants. A procedure has also been developed for total synthesis of the barstar gene with randomization of selected residues and a multiplicity (the number of independently randomized sequences)on the order of 10exp9. We are now screening a synthetic barstar library with randomized hydrophobic cores. The phage display is also being applied to the cloning of barstar homologs from Streptomyces, two of which, for Sa2, have been cloned by conventional methods. The gene yrdF, identified in the the complete sequence of B. subtilis 168 as similar to that of barstar, has been cloned and, after several codon modifications, expressed in E. coli. Although there is no recognizable homolog of barnase in B. subtilis 168, yrdF is an effective inhibitor, in vitro and in vivo, of barnase. An improved system for in vivo selection and testing of barstars has also been developed, using a two plasmid system. - ribonuclease, protein folding, barnase, barstar, Bacillus, Streptomyces, directed mutagenesis, phage display

Agency
National Institute of Health (NIH)
Institute
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Type
Intramural Research (Z01)
Project #
1Z01DK015102-39
Application #
6289714
Study Section
Special Emphasis Panel (LCDB)
Project Start
Project End
Budget Start
Budget End
Support Year
39
Fiscal Year
1999
Total Cost
Indirect Cost
City
State
Country
United States
Zip Code
Krajcikova, Daniela; Hartley, Robert W (2004) A new member of the bacterial ribonuclease inhibitor family from Saccharopolyspora erythraea. FEBS Lett 557:164-8
Mitkevich, Vladimir A; Schulga, Alexey A; Ermolyuk, Yaroslav S et al. (2003) Thermodynamics of denaturation of complexes of barnase and binase with barstar. Biophys Chem 105:383-90
Hartley, R W (2001) Barnase-barstar interaction. Methods Enzymol 341:599-611
Deev, S M; Iazynin, S A; Hartley, R W (2000) [Modified ribonuclease gene provides efficient positive selection in molecular cloning] Mol Biol (Mosk) 34:48-54